Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

More Good News for Amarin
Motley Fool
Friday, March 15, 2013 - 10:58am
tags:
Amarin, Vascepa
Vertex: The Sun Sets On Incivek, Rises On Its CF Franchise
Seeking Alpha
Friday, March 15, 2013 - 10:57am
tags:
Incivek, Vertex Pharmaceuticals, Gilead, GSK, JNJ, Kalydeco, cystic fibrosis, hepatitis C
J&J Subsidiary Cordis Buys Flexible Stenting Solutions
Motley Fool
Friday, March 15, 2013 - 10:55am
tags:
JNJ, Cordis, stents, Flexible Stenting Solutions, M&A
Longer Lasting Drugs Make For Longer Lasting Profits
Seeking Alpha
Friday, March 15, 2013 - 10:54am
tags:
AntriaBio, AstraZeneca, Novo Nordisk, Sanofi, Bristol-Myers Squibb
Drug Deficit Turning India’s Claris Into Target: Real M&A
Bloomberg
Friday, March 15, 2013 - 10:46am
tags:
Claris Lifesciences, M&A, India, Teva, Pfizer
Sinovac vaccine for hand, foot and mouth disease prevents infection in 95 percent of patients
Yahoo/AP
Thursday, March 14, 2013 - 11:41am
tags:
vaccines, Sinovac, hand foot and mouth disease, EV71
Navidea drops after FDA nod for drug used in cancer patients
Fierce Biotech
Thursday, March 14, 2013 - 11:39am
tags:
Navidea Biopharmaceuticals, FDA, breast cancer, Lymphoseek
Diabetes Drugs Are Being Evaluated for Pancreatic Risk
Bloomberg
Thursday, March 14, 2013 - 11:15am
tags:
pancreatic cancer, diabetes, Merck, Januvia, Bristol-Myers Squibb, Byetta, Novo Nordisk, Victoza
Orexigen Therapeutics Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2012
Yahoo
Thursday, March 14, 2013 - 11:13am
tags:
earnings, Orexigen
Boehringer signs hep C pact with Presidio
Pharma Times, UK
Thursday, March 14, 2013 - 10:56am
tags:
hepatitis C, Presidio Pharmaceuticals, Boehringer Ingelheim
With Kythera as Model, Lithera Tests Drug to Shrink ‘Love Handles’
Xconomy
Thursday, March 14, 2013 - 10:55am
tags:
Kythera, Lithera, salmeterol xinafoate
FDA Head Of Generic Drugs Office Resigns
Pharmalot
Thursday, March 14, 2013 - 10:53am
tags:
generics, FDA
KV Pharma Goes After The FDA, Again
Pharmalot
Thursday, March 14, 2013 - 10:52am
tags:
KV Pharmaceutical, FDA
Is AVEO's Tivozanib Any Better Than Placebo For The Treatment Of Renal Cell Carcinoma?
Seeking Alpha
Thursday, March 14, 2013 - 10:51am
tags:
Aveo Pharmaceutical, tivozanib, renal cell carcinoma
Cempra: FDA alert on Zithromax will not affect us
Bizjournals.com
Thursday, March 14, 2013 - 10:50am
tags:
FDA, Cempra, Zithromax, antibiotics, Solithromycin
ArQule Earnings: Everything You Must Know Now
Wall St. Cheat Sheet
Thursday, March 14, 2013 - 10:49am
tags:
earnings, Arqule
FDA wants to relax criteria for Alzheimer's drug approval, NY Times says
Yahoo/Fly on the Wall
Thursday, March 14, 2013 - 10:48am
tags:
Alzheimer's disease, FDA
What's Behind MannKind's Incredible Run?
Motley Fool
Thursday, March 14, 2013 - 8:21am
tags:
MannKind
J&J’s Ekdahl Says Hip Recalled for Clinical Reasons
Bloomberg
Thursday, March 14, 2013 - 8:20am
tags:
JNJ, DePuy, hip impants, recalls
Johnson & Johnson cuts bonuses for new CEO, other execs by 10 percent due to 'disappointments'
Yahoo/AP
Thursday, March 14, 2013 - 8:19am
tags:
JNJ, executive pay

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.